Insights

Competitive Intelligence In Healthcare: Tracking FDA Drug Approvals

For those in the healthcare industry, knowledge of regulatory activities and FDA drug approvals can be critical to competitive intelligence.

Read now
filter by
Healthcare

BIO CEO 2019: The Future Of IPOs And M&As In Biotech

AlphaSense Staff

At the BIO CEO & Investor Conference 2019, AlphaSense discusses the shifting M&A landscape following a record-setting year of biotech IPOs.

Read post
{{ post.topic }}
{{ post.date }}

{{ post.title }}

{{ post.author.name }} {{ post.author.title }}

{{ post.intro }}

Read post

Schedule a demo

To see AlphaSense in action, please fill out the form.

×